Selvita (WAR:SLV) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 27, 2026)


WAR:SLV Selvita SA WAR:SLV
81 GF Score
Price zł31.60
GF Value zł58.46
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Selvita Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Selvita's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

WAR:SLV vs TMO, DHR, IDXX: Margin of Safety % (DCF Earnings Based) Comparison

For the Diagnostics & Research subindustry, Selvita's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Selvita Margin of Safety % (DCF Earnings Based) vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Selvita's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Selvita's Margin of Safety % (DCF Earnings Based) falls into.


WAR:SLV
81GF Score
Selvita SA WAR:SLV
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Selvita (WAR:SLV) Overvalued in 2026?

Based on GuruFocus' analysis, Selvita stock appears to be undervalued. The current stock price of zł31.60 is trading 45.9% below its estimated GF Value™ of zł58.46. GuruFocus considers Selvita to be Significantly Undervalued.

Key valuation signals for WAR:SLV:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: zł58.46 vs. price of zł31.60 (45.9% below fair value)
  • GF Score™: 81/100 with 4 warning signs

No single metric tells the full story. See the WAR:SLV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Selvita Business Description

Other Exchanges 787:Germany
Address Bobrzynskiego 14, Park Life Science, Krakow, POL, 30-348
Selvita SA is a Poland based parent company of Selvita Group is one of the largest preclinical contract research organizations in Europe. It also develops bioinformatics solutions supporting innovative projects at preclinical stages. It also provides services provided to external contractors are in the field of chemistry, analytics, regulatory, biochemistry and cell biology and also the integrated research and development projects.
81GF Score

Get the complete analysis for WAR:SLV

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł31.60
Price
zł58.46
GF Value